Daily Chart

Pfizer Inc (PFE) Financial News - Skowron, Lockhart, Liquor Tax, Credit Suisse, Viagra Patent: Compliance

Pfizer Inc (PFE)

Skowron, Lockhart, Liquor Tax, Credit Suisse, Viagra Patent: Compliance

Quote: Courts Pfizer Wins Viagra Patent-Infringement Case Against Teva Pfizer Inc. (PFE)Teva Pharmaceutical Industries Ltd. (TEVA) from marketing a generic version of the impotence drug Viagra until 2019. U.S. District Judge Rebecca Beach Smith in Norfolk, Virginia, ruled Aug. 12 against Petach Tikva, Israel-based Teva, which claimed the patent wasn’t valid and couldn’t be enforced. “Teva has not shown by clear and convincing evidence that the patent is invalid,” Smith said in a 110-page opinion. In addition, “there is utterly no evidence” to support Teva’s claim that that Pfizer intentionally withheld documents from the U.S. Patent and Trademark Office, Smith wrote. “Protecting the intellectual property rights of our innovative core is critical,” Amy Schulman, Pfizer’s general counsel, said in a statement. “Friday’s court decision acknowledges Teva’s clear violation of our patent rights.” Denise Bradley, a Teva spokeswoman, declined to comment on the ruling. “While we expect Teva to appeal, the ruling represents a clear positive for Pfizer,” said Christopher Schott, a New York-based analyst for JPMorgan Chase & Co., in a note to clients yesterday. He said the ruling is worth about 3 cents to Pfizer’s 2012 earnings per share and about 6 cents to annual earnings per share through 2019. The case is Pfizer v. Teva, 10-cv-128, U.S. District Court, Eastern District of Virginia (Norfolk). Ex-Optionable Chief Admits to Scheme to Hide Bank Losses Optionable Inc. (OPBL)Bank of Montreal. (BMO) Cassidy, 52, pleaded guilty yesterday in Manhattan federal court to one count of conspiracy to commit wire fraud. The judge set a Dec. 15 sentencing date. The case stems from C$680 million ($690.5 million) of pretax commodity-trading losses the bank announced in April 2007. Those losses grew to C$853 million for the fiscal year, paring profit by C$440 ...
Open whole article (external link)

Other Financial and Stock Market News concerning Pfizer Inc

Pfizer Inc Stock Summary

Stocktweeting is not a financial advisor, and in no way recommends the purchase of any stock or advise on the suitability of any trade or investment.
Stock trading and investing can cause loss of capital, and you should always consult with a professional financial advisor before trading or investing.

This website is a service of the HagensMedia ad network. For advertising please visit http://www.hagensmedia.com - Copyright 2011-2012.